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Illicit drug use imposes a large burden on societies globally, leading 
to many deaths each year and a significant number of years of life 
lost (YLL) due to premature mortality or disabilities.[1] The United 
Nations Office on Drugs and Crime (UNODC) estimated in its 2012 
report[2] that 3.4 - 6.6% of the world’s population aged between 15 and 
64 years had used illegal drugs at least once in the previous year, and 
in its 2014 report[3] that globally there were 243 million drug users, 
and that 183 000 drug-related deaths had occurred in 2012.
Information on the extent of drug use and drug-related deaths in Africa 
is extremely limited, as many low-income countries lack the resources and 
expertise to monitor and assess the problem.[4,5] South Africa (SA) has a 
population of approximately 54 million and is believed to be the largest 
trader of illicit drugs in sub-Saharan Africa.[6-8] As a developing country, SA 
has been undergoing radical social transformation in the last few decades, 
making it particularly vulnerable to drug abuse, drug trafficking and crime 
in general.[6,9,10] Other influences predisposing to high levels of drug abuse 
in SA include widespread poverty, poor education, high unemployment 
rates, poor border control and political changes or instabilities.[6,7,10-12]
Accurate and comprehensive data on the nature and extent of drug 
use in SA are particularly difficult to obtain owing to the lack of a 
comprehensive national population study on this problem in recent 
years.[13] Based on the Central Drug Authority (CDA)’s annual report for 
2007/08,[9] drug abuse statistics for SA indicated that an estimated 8.9% of 
the population between the ages of 15 and 64 years used cannabis, 0.4% 
opiates, 0.8% cocaine and 0.9% amphetamine-type stimulants.[9]
Cannabis is the most frequently used illicit drug in SA and is commonly 
used among all ethnic groups.[3,9,12,14] Heroin is also popular, often sold 
in low-grade forms mixed with cannabis at a reduced price (i.e. ‘nyaope’, 
‘ungah’ and/or ‘pinch’), making it more accessible to lower socio economic 
groups.[3,5,9,12,14,15] The use of cocaine seems to have decreased slightly since 
2008, despite a dramatic increase reported between 1996 and 2006. [5,9,16] 
The drug of choice varies across SA, with amphetamine-type stimu-
lants such as ‘tik’ (crystal methamphetamine) being the drug of choice 
in the Western Cape, while ‘CAT’ (methcathinone) is more popular in 
Gauteng.[9] Methaqualone (Mandrax) is also widely used, and although 
there is some indication that its use has declined in recent years, SA still 
remains its largest user in the world.[3,17]
Drug abusers suffer from a higher mortality and shorter life 
expectancy compared with other individuals of the same age group 
in the general population.[18-20] Apart from illicit drugs being the 
primary cause of death, acquired immunodeficiency syndrome 
and hepatitis C contracted from unsafe needle practices, accidental 
fatalities while intoxicated, unpredictable reactions (to drugs and/
or adulterants) and criminal activity or interpersonal violence also 
contribute to mortality associated with illicit drug use.[1,6,20,21]
In SA it is not standard practice to routinely test samples obtained 
at autopsy for the presence of substances other than alcohol, such as 
illicit drugs and/or medicinal substances. The usual/current practice 
at medicolegal mortuaries in SA is that, at the time of performing the 
autopsy, the attending medical practitioner/pathologist will (on an ad 
hoc basis) assess the need to request qualitative and/or quantitative 
testing for illicit drugs (or other specific substances), based on the 
autopsy findings and any relevant or suggestive history that may be 
available at the time (often of a very limited or incomplete nature). This 
may include suspicious or unexpected deaths for which no overt cause is 
initially evident, especially among younger persons. The lack of routine 
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testing may reflect the historically low rate of 
illicit use of drug(s)/substance(s) in SA, but 
is also likely to be a direct consequence of 
resource constraints, as such testing is labour 
and cost intensive. Additionally, in respect 
of analysis of medicolegal samples, there is 
currently a very large backlog of cases at the 
state forensic chemistry laboratories.[22] This 
inability of state toxicology laboratories to 
adequately service the demands of medico-
legal mortuaries (where >50 000 medicolegal 
autopsies are being performed annually) may 
also serve as a disincentive for forensic medical 
practitioners to routinely collect such samples 
at autopsy.
Illicit drug use and drug dependence cause 
considerable harm to individuals and to 
society and have important implications for 
the economy, public health and social policy.[4] 
It is therefore essential to know the extent and 
monitor the nature and patterns of drug use and 
dependence in order to detect emerging threats 
and avoid damaging economic consequences.[23] 
Objective
A review of available data shows a paucity 
of published research in SA that specifically 
investigated illicit drug use in deceased persons 
or attempted to correlate such substances with 
cause or manner of death. The objective 
of this study was therefore to assess the 
presence and profile of drugs (in conjunction 
with demographic characteristics) detected in 
deceased persons on whom forensic medical 
autopsies were performed at the Pretoria 
Medico-Legal Laboratory (PMLL) over the 
10-year period 2003 - 2012.
Methods
The PMLL admits and examines cases of 
unnatural and unexplained deaths from the 
greater part of Pretoria (Tshwane metropolitan 
municipality), the capital city of SA.
A retrospective descriptive study was 
undertaken by reviewing all case files of 
deceased individuals on whom postmortem 
examinations had been conducted at the 
PMLL from 1 January 2003 to 31 December 
2012, in the course of which biological 
specimens (blood, urine, vitreous humour, 
stomach contents, bile, liver or kidney tissue) 
had been collected and submitted for analysis 
in respect of illicit/recreational drugs and 
alcohol. The vast majority of these analyses 
were performed at the National Department 
of Health Forensic Chemistry Laboratory 
(FCL) in Pretoria using standard analytical 
methods including gas chromatography-mass 
spectrometry and ultra-performance liquid 
chromatography-tandem mass spectrometry.
Approval to conduct the study was obtained 
before commencement from the Research Ethics 
Committee of the Faculty of Health Sciences, 
University of Pretoria (ref. no. 143/2014).
Results
Cases identified for inclusion  
in the study
Over the 10-year study period, autopsies were 
performed on 22 566 bodies, and biological 
samples from a total of 385 decedents were 
submitted for illicit drug analysis. Results were 
available for review at the time of conducting 
the study for only 281 of these 385 cases (73.0%) 
owing to the backlog of analyses at the FCL. 
Of the 281 cases analysed, 154 (54.8%) tested 
positive for one or more illicit drugs (Table 1).
Demographic information
The majority of samples submitted for drug 
analysis (79.2%) as well as the majority of 
cases with positive results (90.3%) were from 
males. Of the 154 decedents with positive 
results, 85.1% were white, 11.0% black and 
3.9% of other ethnicity (coloured, Asian 
or Indian) (Table 2). In 51.9% of cases 
with positive results, the decedent had died 
between the ages of 20 and 30 years (Fig. 1).
Table 1. Number of cases submitted, analyses done and positive results obtained (per year) in respect of illicit drugs over the 10-year 
study period (2003 - 2012)
Year
1 2 3 4 5 6 7 8 9 10 Total
Total caseload at PMLL, N 2 266 2 351 2 253 2 364 2 339 2 461 2 341 2 235 2 037 1 919 22 566
Cases submitted for drug analysis, n 40 27 48 42 41 44 34 37 25 47 385
Cases analysed, n 39 27 47 40 36 30 16 22 8 16 281
Cases with positive results, n 20 18 20 18 20 12 9 16 7 14 154
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Fig. 1. Age distribution of cases testing positive for an illicit drug (N=154).
Table 2. Comparison of demographic data of drug-positive cases with all those sent for analysis
Male Female
White Black Other Total White Black Other Total
Cases submitted for analysis (N=385), n 205 71 29 305 48 28 4 80
Positive cases (N=154), n 119 14 6 139 12 3 0 15
Positive cases, % 77.3 9.1 3.9 90.3 7.8 1.9 0 9.7
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Toxicology results
Illicit drugs
Illicit drugs detected in the decedents included opiates (heroin and 
morphine), cocaine, amphetamines, methaqualone and cannabis. 
Heroin was the most common drug detected (n=99, 35.2%) followed 
by cocaine (n=56, 19.9%). Amphetamines and methaqualone were 
relatively rarely detected, being found in only 18 (6.4%) and 12 (4.3%) 
cases, respectively. Cannabis was detected in only 13 cases (4.6%).
No positive results were reported in respect of other drugs of abuse, 
such as psilocybin, lysergic acid diethylamide (LSD), phencyclidine, 
gamma-hydroxybutyrate (GHB) or ketamine.
Alcohol
Testing for alcohol was undertaken in 300 of the 385 study cases. In 
56 of the cases that had tested positive for one or more illicit drugs 
(n=154), the concurrent presence of alcohol was detected, with the 
average blood alcohol concentration (BAC) being 0.10 g/100 mL.
Autopsy findings
In 75 of the total of 385 cases there were signs of decomposition at 
autopsy, suggesting that there had been substantial delays in finding 
the body or retrieving it from the scene of death. On external 
examination, 97 cases revealed needle puncture marks and skin track 
marks possibly associated with intravenous drug use, although it is 
possible that in some cases the puncture marks may have been due 
to resuscitation efforts.
Cause of death
In 109 of the 385 cases (28.3%), the pathologist concluded that the 
cause of death was drug related. The causes of death in the remaining 
276 cases (i.e. those not specifically ascribed to illicit drugs) included 
mainly blunt-force injury (motor vehicle accidents, assaults, falling 
from a height), stab wounds, gunshot wounds, hangings and natural 
causes. In 96 of the cases a history of previous drug use was noted, 
and in 81 cases drug paraphernalia were present at the scene of death.
Discussion
Males (90.3%) accounted for the vast majority of positive cases, 
which is in keeping with other studies.[21,23-26] The most common 
age category for decedents who tested positive for illicit drugs (20 - 
30  years) also correlates relatively well with other studies.[25-27] This 
reflects a life expectancy approximately 32.9 - 42.9 years lower than 
that of the general population of SA (62.9 years)[28] and indicates 
a significant number of YLL, which places a severe financial and 
emotional burden on the economy and communities.
The race/ethnic profile of decedents who tested positive for illicit 
drugs does not reflect the overall racial profile of the population of 
Tshwane: white decedents accounted for 85.1% of positive cases, 
despite only making up 20.1% of the general Tshwane population, 
whereas decedents from Tshwane’s largest population group, black 
Africans (75.4%), only accounted for 11.0% of positive cases.[29] 
These results also do not reflect the population profile of decedents 
admitted to the PMLL, where approximately 76% of all admissions 
are black.[30] A variety of factors may account for these findings, 
including social and cultural norms, socioeconomic factors and the 
availability of drugs.
Heroin was the most common drug detected in this study, followed 
by cocaine. These results are consistent with findings from other 
studies.[24-26,31] It is likely that these drugs are over-represented in 
samples from decedents, as opiates and cocaine are addictive and 
carry a greater risk of fatal outcome owing to the risk of central 
nervous system depression or cardiovascular afflictions, among 
other complications due to chronic use.[32] Globally, differences 
exist in patterns of illicit drug use: in Australia, opioids are believed 
to be responsible for most drug-related deaths, while cocaine 
has been reported as most commonly detected in drug-related 
deaths in Florida, USA.[23,33] The low presence of amphetamines 
and methaqualone in deceased persons may reflect the established 
knowledge that amphetamine users have lower drug-related mortality 
risks than opiate users.[34] Interestingly, Stewart et al.,[35] using data 
obtained from the FCL in Johannesburg, reported methaqualone to 
be the most common drug detected in decedents between 1991 and 
1996, with opiates, cocaine and amphetamines only being detected 
in a very small proportion of cases from the Gauteng area. There 
therefore appears to have been a substantial change in the type of 
drug being used in this region over the past two decades.
The low proportion of cases in our study in which cannabis was 
detected is unexpected, as cannabis has been documented to be 
the most frequently used drug in Gauteng.[14] However, it is known 
that cannabis contributes very little to mortality, as reported in the 
2010 Global Burden of Disease study[36] and also by Lee et al.,[23] 
who found that cannabis resulted in no deaths among decedents in 
Florida despite being the third most commonly detected drug. The 
low incidence of positive cases in our study should nonetheless be 
investigated further. The possibilities exist that long sample storage 
periods before analysis may have affected the integrity of samples or 
the ability to detect the drug, or that metabolite-specific testing had 
not been carried out.[37]
Using two or more illicit substances concurrently increases the 
likelihood of physical or physiological harm and may more often have 
a lethal effect.[38,39] Such combined use is usually intended to make 
the experience more enjoyable or to compensate for a low supply of 
the primary drug/drug of choice.[40] In 39 cases in our study (13.9%) 
the decedent tested positive for more than one illicit drug. The most 
common combination detected was that of heroin and cocaine, 
a combination referred to as ‘speedballing’ among drug users.[41] 
During speedballing, the two drugs are used simultaneously or 
following one another, usually intravenously, and the effect produced 
is a combination of enhanced euphoria and a rush of energy from 
the cocaine.[41]
Besides the individual lethal effects of the various drugs of abuse, 
drug use in younger persons is a major risk factor for fatal accidents 
or injuries, whereas in older drug abusers (≥55 years) use of drugs 
may precipitate death due to underlying cardiovascular disease.[20] 
The high prevalence of suicides, violent behaviour (often resulting 
in interpersonal violence or conflict with law enforcement officers), 
drug-induced disease (such as cocaine cardiomyopathy or infectious 
endocarditis) and unsafe needle practices associated with drug use 
also contribute to drug-related fatalities.[23,27]
Alcohol was detected in combination with one or more illicit drugs 
in 36.4% of our study cases, with the highest BAC recorded being an 
exceptionally high level of 0.47 g/100 mL, present in a victim who 
also tested positive for cannabis and methaqualone (a combination 
suggesting the use of what is colloquially referred to as ‘white pipe’). 
The influence of illicit drugs on an individual can be unpredictable 
and when taken in combination with alcohol, the effect may be 
exaggerated or harmful, as may be seen when alcohol is consumed 
with cocaine, leading to the production of cocaethylene.[32]
In SA, forensic pathologists/medical practitioners attempt to 
establish the primary medical cause as well as the mode or mechanism 
of death, based primarily on autopsy and related findings. No formal 
finding is made by the forensic medical practitioner as to the 
manner of death (i.e. homicide, suicide, accident or natural cause). 
In equivocal cases, inquests are held where the presiding magistrate 
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must ultimately make a finding as to the cause and manner of death. 
The results of toxicological testing cannot be considered in isolation 
when concluding the cause, mechanism or manner of death, the 
latter often being a complex decision involving the consideration 
of a range of factors. Establishing whether the presence of a drug in 
the body fluids or tissues of a deceased person played a material role 
in bringing about the death of that person can only be concluded 
on the basis of thorough assessment of all factors surrounding the 
case, including the circumstances of death, clinical parameters and 
actual drug concentrations. It also needs to be considered that in 
most cases, illicit drugs are produced in clandestine laboratories 
where no safety or quality control measures exist in the production 
process. It is common to find that these illicit drugs contain multiple 
active compounds as well as additives (adulterants and/or ‘cutting’ 
agents) that may in themselves be extremely harmful and may 
cause toxic, allergic or even anaphylactic reactions.[42] It is therefore 
very important (in the context of both civil and criminal justice 
administration) for the forensic medical practitioner to have regard 
for, and access to, relevant information such as death scene findings, 
medical history, prior use of drugs or medications and consumption 
of alcohol.[43]
Several factors may have impacted negatively on the results of 
this study. Firstly, the long delay in the analysis of samples could 
have compromised the accuracy of the results, both qualitatively and 
quantitatively. Samples are biodegradable and substances therein may 
be subject to decay or changes over time.[44,45] Secondly, the limited 
information that may be contemporaneously available to the forensic 
medical practitioner at the time of the autopsy could have led to an 
under-selection of cases for drug analysis. In addition, the presence 
of decomposition may significantly lower the chance of detecting 
drugs as a result of secondary chemical changes or degradation of 
substances.[46,47] Owing to unavailability of quantitative analysis in 
many cases (or because long delay periods before sample analysis may 
preclude reliable quantification), pathologists may be compromised 
in attributing the death specifically to a drug overdose or interaction.
This study revealed a very low assessment rate, only 1.7% of 
decedents being subjected to analysis and illicit/recreational drugs 
being present in only 0.7% of the total caseload admitted to the 
mortuary. This is in stark contrast to the norms and practice 
that may be expected of an efficient medicolegal investigation-of-
death service. A review of all forensic autopsy cases conducted at 
medicolegal centres in Alabama, USA, and Osaka City, Japan, where 
routine screening had been performed found that drugs of abuse 
were detected in 33.7% and 16.2% of cases, respectively.[48,49]
Based on the available epidemiological information and statistics 
from agencies such as the UNODC, the South African Community 
Epidemiology Network on Drug Use and the CDA, there is reason to 
believe that a substantially higher rate of detection of illicit substances 
is to be expected in victims who undergo medicolegal autopsies in 
SA. It is clear that very limited inference as to the probable prevalence 
and use of these substances in decedents examined at medicolegal 
mortuaries can be drawn from the results of analyses based on such 
low sample figures. The lower proportion of cases analysed at the 
FCL from 2006 onwards indicates that the system has become less 
efficient in recent years. It is likely that over the 10-year period there 
were substantially more cases in which illicit drugs were implicated in 
or had contributed to the death of the individual. It would therefore 
be beneficial for routine screening to be considered and more studies 
of this nature to be conducted, preferably in the form of controlled, 
prospective studies, to better establish the nature and prevalence of 
illicit drugs in the subset of the population who undergo postmortem 
examinations, as a possible measure of the use and distribution of 
such substances in the SA community. This will also provide valuable 
information on the circumstances surrounding these preventable 
deaths in order to inform appropriate responses and interventions.
Conclusions
Results from this study indicate that investigations of fatalities 
believed to be associated with illicit drug use are a frequent (almost 
weekly) occurrence at the PMLL. Nonetheless, it is likely that the 
results obtained from this study are a gross under-representation of 
the actual number of drug users who have died during the 10-year 
period as a result of the direct or indirect causes mentioned above. 
The importance of improving the toxicology situation is two-fold. 
Firstly, when an unexpected or unnatural death of this nature occurs, 
the cause/manner of death has far-reaching implications in terms 
of possible criminal prosecution, insurance payouts and/or closure 
for grieving family members. Secondly, the role that these drugs 
(and associated components) play in the cause and/or manner of 
death should be elucidated in SA, and this will only be possible if 
consideration is given to future routine drug screening on unnatural 
deaths at medicolegal mortuaries. This will allow more accurate data 
to be obtained for the purpose of public health programmes and add 
insight into the illicit drug use situation in SA. In order to achieve 
this, the capacity of our national FCLs will need to be substantially 
improved.
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